Author

Franck Zal

Hemarina (France)ORCID 0000-0002-2872-6618Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Benoı̂t BarrouiD· 1 shared Jean‐Benoît ArletiD· 1 shared Laurent Alexandre LantieriiD· 1 shared Leïla DeminiiD· 1 shared Olivier HermineiD· 1 shared Rachel Rignault‐Bricard· 1 shared Thiago Trovati MacieliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Benoı̂t BarrouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Therapeutic potential of oxygen through M101 transportation in reducing vaso-occlusion and hemolysis in a mouse model of sickle cell disease.

Franck Zal, Rachel Rignault‐Bricard, Leïla Demini, Benoı̂t Barrou, Laurent Alexandre Lantieri, Olivier Hermine, Jean‐Benoît Arlet, Thiago Trovati Maciel

This study evaluates M101, a marine-derived hemoglobin-based oxygen carrier, in a mouse model of sickle cell disease, showing reduced RBC sickling, hemolysis, and vaso-occlusion.

bioRxiv · Jun 18, 2025 · PreprintPathology